There were 568 press releases posted in the last 24 hours and 397,857 in the last 365 days.

Cyclacel Seeks $9.5 Million In Registered Direct Offering

January 13, 2010, 2010 (FinancialWire) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP) has entered into definitive agreements to raise $7.2 million in gross proceeds, before deducting placement agent fees and other estimated offering expenses, and up to an additional $2.3 million, in a registered direct offering with select institutional investors.

“The proceeds of the financing together with our current cash, cash equivalents and marketable securities should provide the financial resources to continue clinical development of sapacitabine and seliciclib, the company’s lead drugs. We will be submitting a Special Protocol Assessment request for a pivotal study of sapacitabine in patients with hematological malignancies during the first quarter of 2010,” said Spiro Rombotis, president and CEO of Cyclacel.

The offering includes the sale and issuance of 2.85 million units, each unit consisting of one share of the company’s common stock and a cash warrant to purchase 0.25 shares of common stock, at a purchase price of $2.51 per unit. The warrants, which represent the right to acquire an aggregate of 712,500 shares of common stock at an exercise price of $3.26 per share, have a five-year term from the date of issuance and are exercisable beginning six months after the date of issuance. The units were offered and sold pursuant to a prospectus supplement dated January 11, 2010 and an accompanying prospectus dated February 12, 2007, pursuant to the company’s effective shelf registration statement previously filed with the Securities and Exchange Commission.

Roth Capital Partners, LLC served as the sole placement agent for the offering. Merriman Curhan Ford & Co. served as financial advisor. The sale is expected to close on or about January 13, 2010.

FinancialWire(tm) is committed to serving the financial community through true journalism and by providing relevant, reliable resources to investors.

Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate written by FIRST Research Consortium member-providers. Obtain reports by writing to research@investrend.com with “Report Request” in the subject line. Recent reports include Palm, Inc. (NASDAQ: PALM), Research In Motion Ltd. (NASDAQ: RIMM), Oracle Corp. (NASDAQ: ORCL), Novell, Inc. (NASDAQ: NOVL), Brocade Communications Systems, Inc. (NASDAQ: BRCD), Autodesk, Inc. (NASDAQ: ADSK), Dell, Inc. (NASDAQ: DELL), Hewlett Packard Co. (NYSE: HPQ), NetApp, Inc. (NASDAQ: NTAP), Advanced Micro Devices, Inc. (NYSE: AMD), Intel Corp. (NASDAQ: INTC), Conexant Systems, Inc. (NASDAQ: CNXT), Monument Mining Ltd. (TSX Venture: MMY), Lovitt Resources Ltd. (TSX Venture: LRC), Lion Energy Corp. (TSX Venture: LEO), PMI Gold Corp. (TSX Venture: PMV), Western Copper Corp. (TSX: WRN), Coral Gold Resources Ltd. (TSX Venture: CLH), Great Plains Exploration, Inc. (TSX: GPX), Kalahari Resources, Inc. (TSX Venture: KLA), Enterprise Oilfield Group (TSX: E), Sultan Minerals, Inc. (TSX Venture: SUL), Blugrass Energy, Inc. (OTCBB: BLUG), Kodiak Energy, Inc. (OTCBB: KDKN), Tamm Oil & Gas, Inc. (OTCBB: TAMO), Carbon Friendly Solutions, Inc. (TSX Venture: CFQ), MIV Therapeutics, Inc. (OTCBB: MIVI), Crocs, Inc. (NASDAQ: CROX), GetFugu, Inc. (OTCBB: GFGU), SpongeTech Delivery Systems, Inc. (OTCBB: SPNG), Advanced Visual Systems, Inc. (OTC: AVSC), Axion International Holdings, Inc. (OTCBB: AXIH), Bark Group, Inc. (OTCBB: BKPG), Beacon Enterprise Solutions Group, Inc. (OTCBB: BEAC), Brainstorm Cell Therapeutics, Inc. (OTCBB: BCLI), China Organic Agriculture, Inc. (OTCBB: CNOA), China Voice Holding Corp. (OTC: CHVC), Crystal International Travel Group, Inc. (OTC: CINT), Devine Entertainment Corp. (OTC: DVNNF), Document Capture Technologies, Inc. (OTCBB: DCMT), Duke Mining Co. (OTCBB: BXWD), Elephant Talk Communications OTCBB: ETAK), Guardian Technologies International, Inc. (OTCBB: GDTI), Home System Group (OTCBB: HYST), IceWEB, Inc. (OTCBB: IWEB), ID Watchdog, Inc. (TSX Venture: IDW) (OTC: IDWAF), Ideal Financial Solutions, Inc. (OTC: IFSL), and CelLynx Group, Inc. (OTCBB: CYNX).

Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). Recently issued reports and filings include Weatherford International Ltd. (NYSE: WFT), UQM Technologies, Inc. (AMEX: UQM), Panhandle Oil and Gas, Inc. (NYSE: PHX), Encore acquisition Company (NYSE: EAC), Altius Minerals Corp. (TSX: ALS), PKC Group Oyj (PLUS: PKC1V) and Standard Life Investments European Private Equity Trust PLC (LSE: SEP) (PLUS: SEP).

FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/). Recently webcast company presentations, financial results & earnings calls now available include Rick’s Cabaret International, Inc. (NASDAQ: RICK) and Applied Signal Technology, Inc. (NASDAQ: APSG). Recordings are accessible via the search function at http://infoescrow.net/f/?u=http://www.investorcalendar.com by entering any company’s ticker symbol into the search field.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.